Volume 34, Issue 7 p. 1082-1084
Letters: New Observations

Engrailed-1 induces long-lasting behavior benefit in an experimental Parkinson primate model

Nitza Thomasson PhD

Nitza Thomasson PhD

BrainEver, Paris, France

Search for more papers by this author
Elsa Pioli PhD

Elsa Pioli PhD

Motac Neuroscience, Manchester, UK

Search for more papers by this author
Claire Friedel MSc

Claire Friedel MSc

BrainEver, Paris, France

Search for more papers by this author
Arnaud Monseur PhD

Arnaud Monseur PhD

Arlenda, Mont-St-Guibert, Belgium

Search for more papers by this author
Jérémie Lavaur PhD

Jérémie Lavaur PhD

BrainEver, Paris, France

Search for more papers by this author
Kenneth L. Moya PhD

Kenneth L. Moya PhD

Center for Interdisciplinary Research in Biology, Collège de France, Centre National de la Recherche Scientifique Unité Mixte de Recherche Paris-Sciences-Lettres 7241, INSERM U1050, Labex Memolife, PSL Research University, Paris, France

Search for more papers by this author
Erwan Bezard PhD

Erwan Bezard PhD

Motac Neuroscience, Manchester, UK

Université de Bordeaux, Institut des Maladies Neurodégénératives, Bordeaux, France

Centre National de la Recherche Scientifique Unité Mixte de Recherche 5293, Institut des Maladies Neurodégénératives, Bordeaux, France

Search for more papers by this author
Anne Bousseau MD

Anne Bousseau MD

BrainEver, Paris, France

Search for more papers by this author
Alain Prochiantz PhD

Corresponding Author

Alain Prochiantz PhD

Center for Interdisciplinary Research in Biology, Collège de France, Centre National de la Recherche Scientifique Unité Mixte de Recherche Paris-Sciences-Lettres 7241, INSERM U1050, Labex Memolife, PSL Research University, Paris, France

Correspondence to: Dr. Alain Prochiantz, Center for Interdisciplinary Research in Biology, Collège de France, 11 Place Marcelin Berthelot, 75231 Paris Cedex 05, France; E-mail: [email protected]Search for more papers by this author
First published: 11 May 2019
Citations: 8
Correction added on July 10, 2019, after first online publication: Figure 1 image has been updated.

Funding agency: This study was supported by BrainEver.

Relevant conflicts of interests/financial disclosures: E.P. is an employee of Motac Neuroscience Ltd, a contract research organization. E.B. has an equity stake in Motac Holding Ltd and receives consultancy payments from Motac Neuroscience Ltd. Current grant support includes Agence Nationale de la Recherche (E.B.), China Science Fund (E.B.), Michael J Fox Foundation for Parkinson Research (E.B.), France Parkinson (E.B.), Fondation de France (E.B.), Medical Research Council (E.B.), Innovative Medicines Initiative (H2020, Inhibiting Misfolded Protein Degradation [IMPRIND]) (E.B.), Initiative of Excellence Bordeaux (IDEX) (E.B.), Center of Excellence on Neurodegeneration (COEN) (E.B.), Multiple System Atrophy Coalition (MSA) (E.B.), Rotary Foundation (E.B.), Nouvelle-Aquitaine Regional Council (E.B.), and LABEX Brain (E.B.). K.L.M. and A.P. are cofounders and hold equity stakes in BrainEver. The author authors have nothing to disclose.

No abstract is available for this article.